MedPath

To compare the efficacy and impact on sexual function of combination of Tadalafil and Tamsulosin versus Tamsulosin alone in the management of Benign prostatic hyperplasia in patients attending Lagos State University Teaching Hospital

Phase 3
Conditions
Urological and Genital Diseases
Registration Number
PACTR202311592558473
Lead Sponsor
Atobatele Kazeem
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
182
Inclusion Criteria

Patients must be 45 years and above with mild to moderate IPSS (0-19)
Patients with PSA less than or equals 4ng/ml, normal DRE and imaging studies
Patients with peak flow rate less than 15mls/sec and PVR greater than or equals 50mls
Patients who give verbal and written consent to the study

Exclusion Criteria

Patients with severe IPSS, PSA greater than 4ng/ml and peak flow rate greater than 15mls/sec.
Patients with PVR less than 50mls.
Contraindications to study medications.
Patients with no sexual partner during the study period

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
International prostatic symptoms score
Secondary Outcome Measures
NameTimeMethod
Quality of life, erectile function, maximum urinary flow rate and post-void residual urine volume
© Copyright 2025. All Rights Reserved by MedPath